NASDAQ:BRTX
BioRestorative Therapies, Inc. Stock News
$2.09
+0.0600 (+2.96%)
At Close: Jun 20, 2024
BioRestorative Therapies to Present at the Dawson James Securities 7th Annual Small Cap Growth Conference
07:00am, Wednesday, 28'th Sep 2022
MELVILLE, NY., Sept. 28, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therap
4 Top Penny Stocks To Buy Right Now According To Insiders
03:52pm, Thursday, 06'th Jan 2022
Insiders decided to buy these penny stocks recently The post 4 Top Penny Stocks To Buy Right Now According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.
BioRestorative Therapies to Present at H.C. Wainwright BioConnect Virtual Conference
06:00am, Thursday, 06'th Jan 2022
MELVILLE, N.Y., Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ: BRTX ), a life sciences company focused on stem cell-based therapies
Best Penny Stocks to Buy in January 2022? Check These 3 Out
09:55am, Thursday, 23'rd Dec 2021
Check these penny stocks out for your January 2022 watchlist The post Best Penny Stocks to Buy in January 2022? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information | P
BioRestorative Therapies Stock (BRTX): Why The Price Surged Today
06:39am, Wednesday, 22'nd Dec 2021
The stock price of BioRestorative Therapies Inc (NASDAQ: BRTX) increased by over 45% pre-market today. This is why it happened.
BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
09:00am, Thursday, 23'rd Sep 2021
MELVILLE, N.Y., Sept. 23, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“ BioRestorative ” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapie
BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
09:00am, Thursday, 02'nd Sep 2021
Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use
BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook
06:00am, Thursday, 19'th Aug 2021
MELVILLE, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
11:58am, Monday, 09'th Aug 2021
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX ), a life sciences company focused on stem cell-based therapies, today announced that
BioRestorative Therapies to Present at the Emerging Growth Conference on June 9, 2021
06:00am, Monday, 07'th Jun 2021
BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference.
BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
06:00am, Monday, 10'th May 2021
MELVILLE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX ), a life sciences company focused on stem cell-based therapies,
BioRestorative Therapies Announces Compliance with SEC Reporting Requirements and “Stop Sign” Removal
06:00am, Monday, 03'rd May 2021
MELVILLE, N.Y., May 03, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, t
BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors
06:27am, Monday, 05'th Apr 2021
MELVILLE, N.Y., April 05, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,
BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program
07:03am, Wednesday, 31'st Mar 2021
Notice of Allowance Grants Protection for Deriving Exosomes from Brown Adipocytes Notice of Allowance Grants Protection for Deriving Exosomes from Brown Adipocytes
BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoStem® Program
06:00am, Monday, 22'nd Mar 2021
MELVILLE, N.Y., March 22, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that th
